Our firm is investigating claims involving acute phosphate nephropathy, an acute kidney injury, caused by oral sodium phosphate (OSP) products. OSPs, such as Fleet Phospho-soda, have been available for years as a laxative. More recently, OSPs have been used as a bowel cleanser prior to colonoscopy and other medical procedures.
Acute phosphate nephropathy (or acute nephrocalcinosis) is caused by calcium-phosphate crystal being deposited in the renal tubules. The deposits cause permanent renal function impairment. In some cases, renal function gradually worsens requiring dialysis and eventually renal transplant.
On December 11, 2008, the Food and Drug Administration issued a statement requiring the manufacturers of OsmoPrep and Visicol, the two OSPs available by prescription, to include a Boxed Warning in their product labels. The FDA further stated that over-the counter laxatives, such as Fleet Phospho-soda, should not be used for bowel cleansing procedures. As a result of the FDA’s statement, on December 12, 2008, C.B. Fleet issued a product recall of both Fleet Phospho-soda Oral Saline Laxative and Fleet Phospho-soda EZ-PREP Bowel Cleansing System.
Thus far our firm has filed two lawsuits for individuals who now suffer chronic renal failure as a result of ingesting Fleet Phospho-soda. We are investigating numerous other claims involving Fleet Phospho-soda, and we will be filing additional lawsuits in the near future. If you need more information contact Roger Smith at 800-898-2034 or Roger.Smith@beasleyallen.com.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.